| Similar Articles |
|---|
 |
The Motley Fool
March 12, 2007
Ryan Fuhrmann |
Esoteric Results at Bio-Reference Labs Bio-Reference Labs is a small firm in the lab-testing field, but worth a look from investors.   |
The Motley Fool
June 6, 2007
Ryan Fuhrmann |
Foolish Forecast: Bio-Reference Labs Nudges Competitors The clinical laboratory testing company is set to release it second-quarter earnings report. Investors, here is what you can expect to see. |
The Motley Fool
April 20, 2007
Ryan Fuhrmann |
Diagnosing Quest Diagnostics Quest should recover from a recent, painful contract loss. Shares trade for a reasonable 17.5 times earnings, and even lower multiple of free cash flow. |
The Motley Fool
September 6, 2007
Ryan Fuhrmann |
Bio-Reference Labs Passes the Test Small-cap lab-testing firm Bio-Reference Labs third-quarter results beat analysts projections by a decent margin, again proving it can compete with the big boys in the highly competitive New York metro area. |
The Motley Fool
October 24, 2006
Ryan Fuhrmann |
LabCorp's Positive Results The good times continue. After taking a major client from Quest Diagnostics, the company reports strong third-quarter earnings. |
The Motley Fool
July 25, 2007
Ryan Fuhrmann |
The Latest Procedure From Quest Diagnostics Quest Diagnostics took a hit earlier this year from the loss of a major contract, but the lab testing firm isn't down for the count. |
The Motley Fool
September 5, 2007
Ryan Fuhrmann |
Foolish Forecast: A Test From BioReference Labs In advance of lab-testing firm BioReference Labs Q3 earnings report, analysts are predicting another quarter of double-digit earnings for the small but fast-growing regional company. |
The Motley Fool
February 15, 2007
Ryan Fuhrmann |
LabCorp Takes Names Things are going well at LabCorp, but not so well at Quest Diagnostics. Still, the long-term attractiveness of the lab testing industry is favorable as the industry consolidates and demographics support increasing healthcare services. |
The Motley Fool
February 8, 2007
Rich Duprey |
Foolish Forecast: LabCorp Tests Positive The clinical lab-testing outfit is set to report its fourth-quarter 2006 earnings. Investors, here is what you can expect to see. |
The Motley Fool
March 9, 2007
Ryan Fuhrmann |
Referencing Bio-Reference's Q1: Fool by Numbers The Northeastern clinical lab test provider released first-quarter 2007 results. Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool
July 26, 2007
Ryan Fuhrmann |
LabCorp Leaps Forward LabCorp continues to fire on all cylinders. Investors, take note. |
The Motley Fool
April 19, 2007
Ryan Fuhrmann |
Quest Diagnostics Becomes Un-United: Fool by Numbers The lab-testing firm released first-quarter 2007 results: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool
April 27, 2007
Ryan Fuhrmann |
LabCorp Tests Positive LabCorp is doing well focusing on managed care -- so far. Recent results were "outstanding by every measure" and could signal even better things to come. Investors, take note. |
BusinessWeek
June 25, 2007
Gene G. Marcial |
Good Results At Bio-Reference Labs Specialty testing is delivering solid earnings for Bio-Reference Laboratories, the third-largest U.S. clinical test outfit. |
The Motley Fool
October 5, 2006
Rich Smith |
Great Chemistry at Lab Corp UnitedHealth Group has canceled its lab-testing contract with Quest and named Lab Corp. as its new service provider. This is an interesting situation for investors. |
The Motley Fool
July 24, 2006
Ryan Fuhrmann |
The Quest for Market Share Quest Diagnostics' second-quarter earnings mostly meet expectations. What might the future hold for investors? |
The Motley Fool
April 16, 2008
Ryan Fuhrmann |
MEDTOX Fails the Test The Motley Fool - MEDTOX posted a weak quarter from a tough job market. |
The Motley Fool
December 16, 2010
Travis Hoium |
Bio-Reference Laboratories Shares Plunged: What You Need to Know Shares of laboratory service provider Bio-Reference Laboratories fell 10% briefly today after the company released earnings. |
The Motley Fool
September 7, 2005
Stephen D. Simpson |
The Little Lab That Could Bio-Reference is a small business with big potential. The company has an appealing cancer and genomics business (GenPath). For investors seeking successful yet unknown companies, this one is worth watching. |
The Motley Fool
July 21, 2005
W.D. Crotty |
The Lab Is Fab Laboratory Corporation of America produces more healthy results. Quest is a better value today based on earnings growth, but both companies are an excellent bet. |
The Motley Fool
February 4, 2011
Brian Orelli |
Glaxo Sold Quest Shares. Should You? Glaxo has somewhere else to spend the capital. Do you? |
The Motley Fool
December 9, 2011
Paul Chi |
3 Europe-Proof Stocks for Your Portfolio These health-care stocks are Europe-proof. |
The Motley Fool
February 13, 2009
Brian Orelli |
Lynch Would Love This Company Double-digit revenue growth in this market is nothing to sneeze at, but that's what LabCorp has delivered. |
The Motley Fool
February 17, 2005
Rich Smith |
LabCorp Tests Positive The results show strong bottom-line growth for the health-care test provider. Compared to the pricier Quest, it's at least a relative bargain price at which investors can own an interest in this essential piece of the health-care market. |
The Motley Fool
April 12, 2007
Rich Duprey |
Foolish Forecast: Checking UnitedHealth's Vitals The health services provider will report its first-quarter 2007 financial results shortly. Investors, here is what you can expect to see. |
Managed Care
April 2007
Scott Kober |
Managed Care Seeks More from Clinical Laboratories Contracting advantage has sometimes been with the nationwide labs, but health plans are getting serious about price, service, and patient data. |
The Motley Fool
April 26, 2007
Ryan Fuhrmann |
LabCorp Measures Up: Fool by Numbers The lab testing firm released results for the first quarter 2007: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
